194 related articles for article (PubMed ID: 17366882)
21. Biosynthesis of enantiopure (S)-3-hydroxybutyric acid in metabolically engineered Escherichia coli.
Lee SH; Park SJ; Lee SY; Hong SH
Appl Microbiol Biotechnol; 2008 Jun; 79(4):633-41. PubMed ID: 18461320
[TBL] [Abstract][Full Text] [Related]
22. [Biosynthesis of chitooligosaccharides by recombinant Escherichia coli].
Zhang DW; Chu J; Hao YR; Li MH; Wang P
Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):525-9. PubMed ID: 17578006
[TBL] [Abstract][Full Text] [Related]
23. Genetic and biochemical characterization of exopolysaccharide biosynthesis by Lactobacillus delbrueckii subsp. bulgaricus.
Lamothe GT; Jolly L; Mollet B; Stingele F
Arch Microbiol; 2002 Sep; 178(3):218-28. PubMed ID: 12189423
[TBL] [Abstract][Full Text] [Related]
24. Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli.
Lee WH; Pathanibul P; Quarterman J; Jo JH; Han NS; Miller MJ; Jin YS; Seo JH
Microb Cell Fact; 2012 Apr; 11():48. PubMed ID: 22545760
[TBL] [Abstract][Full Text] [Related]
25. [Progress in metabolism and crucial enzymes of glycerol conversion to 1,3-propanediol].
Tian PF; Tan TW
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):201-5. PubMed ID: 17460888
[TBL] [Abstract][Full Text] [Related]
26. Towards tailor-made oligosaccharides-chemo-enzymatic approaches by enzyme and substrate engineering.
Homann A; Seibel J
Appl Microbiol Biotechnol; 2009 May; 83(2):209-16. PubMed ID: 19357843
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of nucleotide sugars and α-galacto-oligosaccharides by recombinant Escherichia coli cells with trehalose substrate.
Ryu SI; Lee SB
Enzyme Microb Technol; 2013 Oct; 53(5):359-63. PubMed ID: 24034436
[TBL] [Abstract][Full Text] [Related]
28. Structure/function relationship of homopolysaccharide producing glycansucrases and therapeutic potential of their synthesised glycans.
Korakli M; Vogel RF
Appl Microbiol Biotechnol; 2006 Aug; 71(6):790-803. PubMed ID: 16724190
[TBL] [Abstract][Full Text] [Related]
29. Production of Lewis x tetrasaccharides by metabolically engineered Escherichia coli.
Dumon C; Bosso C; Utille JP; Heyraud A; Samain E
Chembiochem; 2006 Feb; 7(2):359-65. PubMed ID: 16381046
[TBL] [Abstract][Full Text] [Related]
30. [High level expression of PNGase F in Escherichia coli and its bioactivities].
Su YS; Wang SJ; Wang P; Qi QS
Sheng Wu Gong Cheng Xue Bao; 2005 Nov; 21(6):911-5. PubMed ID: 16468345
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of oligosaccharides by bacterial enzymes.
Johnson KF
Glycoconj J; 1999 Feb; 16(2):141-6. PubMed ID: 10612413
[TBL] [Abstract][Full Text] [Related]
32. Kdo-(2 --> 8)-Kdo-(2 --> 4)-Kdo but not Kdo-(2 --> 4)-Kdo-(2 --> 4)-Kdo is an acceptor for transfer of L-glycero-alpha-D-manno-heptose by Escherichia coli heptosyltransferase I (WaaC).
Gronow S; Lindner B; Brade H; Müller-Loennies S
Innate Immun; 2009 Feb; 15(1):13-23. PubMed ID: 19201821
[TBL] [Abstract][Full Text] [Related]
33. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes.
Arnér ES; Sarioglu H; Lottspeich F; Holmgren A; Böck A
J Mol Biol; 1999 Oct; 292(5):1003-16. PubMed ID: 10512699
[TBL] [Abstract][Full Text] [Related]
34. Interplay of the Wzx translocase and the corresponding polymerase and chain length regulator proteins in the translocation and periplasmic assembly of lipopolysaccharide o antigen.
Marolda CL; Tatar LD; Alaimo C; Aebi M; Valvano MA
J Bacteriol; 2006 Jul; 188(14):5124-35. PubMed ID: 16816184
[TBL] [Abstract][Full Text] [Related]
35. Efficient production of active Vibrio proteolyticus aminopeptidase in Escherichia coli by co-expression with engineered vibriolysin.
Sonoda H; Daimon K; Yamaji H; Sugimura A
Appl Microbiol Biotechnol; 2009 Aug; 84(1):191-8. PubMed ID: 19557407
[TBL] [Abstract][Full Text] [Related]
36. Disruption of a global regulatory gene to enhance central carbon flux into phenylalanine biosynthesis in Escherichia coli.
Tatarko M; Romeo T
Curr Microbiol; 2001 Jul; 43(1):26-32. PubMed ID: 11375660
[TBL] [Abstract][Full Text] [Related]
37. High cell density culture of metabolically engineered Escherichia coli for the production of poly(3-hydroxybutyrate) in a defined medium.
Wang F; Lee SY
Biotechnol Bioeng; 1998 Apr 20-May 5; 58(2-3):325-8. PubMed ID: 10191411
[TBL] [Abstract][Full Text] [Related]
38. Large-scale production of oligosaccharides using engineered bacteria.
Endo T; Koizumi S
Curr Opin Struct Biol; 2000 Oct; 10(5):536-41. PubMed ID: 11042450
[TBL] [Abstract][Full Text] [Related]
39. Glycosyltransferases involved in the biosynthesis of biologically active natural products that contain oligosaccharides.
Luzhetskyy A; Vente A; Bechthold A
Mol Biosyst; 2005 Jul; 1(2):117-26. PubMed ID: 16880973
[TBL] [Abstract][Full Text] [Related]
40. lfnA from Pseudomonas aeruginosa O12 and wbuX from Escherichia coli O145 encode membrane-associated proteins and are required for expression of 2,6-dideoxy-2-acetamidino-L-galactose in lipopolysaccharide O antigen.
King JD; Mulrooney EF; Vinogradov E; Kneidinger B; Mead K; Lam JS
J Bacteriol; 2008 Mar; 190(5):1671-9. PubMed ID: 18156256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
